Some treatments for IBD, such as immunosuppressive medications and biologics, can potentially influence cancer risk. For instance, long-term use of immunosuppressants may increase the risk of lymphomas and skin cancers. However, the benefits of controlling IBD often outweigh these risks. Close monitoring and regular screenings are essential for early detection and management.
